{"id":"https://openalex.org/W1496898730","doi":null,"title":"Antitumor activity of P-4055 (elaidic acid-cytarabine) compared to cytarabine in metastatic and s.c. human tumor xenograft models.","display_name":"Antitumor activity of P-4055 (elaidic acid-cytarabine) compared to cytarabine in metastatic and s.c. human tumor xenograft models.","publication_year":1999,"publication_date":"1999-06-15","ids":{"openalex":"https://openalex.org/W1496898730","mag":"1496898730","pmid":"https://pubmed.ncbi.nlm.nih.gov/10383159"},"language":"en","primary_location":{"id":"pmid:10383159","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/10383159","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer research","raw_type":"Comparative Study"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5082518497","display_name":"Knut Breist\u00f8l","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I184942183","display_name":"University of Oslo","ror":"https://ror.org/01xtthb56","country_code":"NO","type":"education","lineage":["https://openalex.org/I184942183"]}],"countries":["NO"],"is_corresponding":false,"raw_author_name":"K Breist\u00f8l","raw_affiliation_strings":["Department of Tumor Biology, The Norwegian Radium Hospital, Oslo","University of Oslo#TAB#"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Tumor Biology, The Norwegian Radium Hospital, Oslo","institution_ids":[]},{"raw_affiliation_string":"University of Oslo#TAB#","institution_ids":["https://openalex.org/I184942183"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038319371","display_name":"Jan M. Balzarini","orcid":"https://orcid.org/0000-0003-2240-3321","observed_orcids":["https://orcid.org/0000-0003-2240-3321","https://orcid.org/0000-0003-1144-1808"]},"institutions":[{"id":"https://openalex.org/I24156275","display_name":"Rega Institute for Medical Research","ror":"https://ror.org/03w5j8p12","country_code":"BE","type":"facility","lineage":["https://openalex.org/I24156275"]}],"countries":["BE"],"is_corresponding":false,"raw_author_name":"J Balzarini","raw_affiliation_strings":["Rega Institute for Medical Research"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Rega Institute for Medical Research","institution_ids":["https://openalex.org/I24156275"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060723543","display_name":"Marit Liland Sandvold","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"M L Sandvold","raw_affiliation_strings":["Equinor Asa"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Equinor Asa","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5018573283","display_name":"Finn Myhren","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"F Myhren","raw_affiliation_strings":["Equinor Asa"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Equinor Asa","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034576327","display_name":"Marita Martinsen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I184942183","display_name":"University of Oslo","ror":"https://ror.org/01xtthb56","country_code":"NO","type":"education","lineage":["https://openalex.org/I184942183"]}],"countries":["NO"],"is_corresponding":false,"raw_author_name":"M Martinsen","raw_affiliation_strings":["University of Oslo#TAB#"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Oslo#TAB#","institution_ids":["https://openalex.org/I184942183"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040662398","display_name":"Erik De Clercq","orcid":"https://orcid.org/0000-0002-2985-8890","observed_orcids":["https://orcid.org/0000-0002-2985-8890"]},"institutions":[{"id":"https://openalex.org/I24156275","display_name":"Rega Institute for Medical Research","ror":"https://ror.org/03w5j8p12","country_code":"BE","type":"facility","lineage":["https://openalex.org/I24156275"]}],"countries":["BE"],"is_corresponding":false,"raw_author_name":"E De Clercq","raw_affiliation_strings":["Rega Institute for Medical Research"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Rega Institute for Medical Research","institution_ids":["https://openalex.org/I24156275"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5113522568","display_name":"\u00d8ystein Fodstad","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"O Fodstad","raw_affiliation_strings":["Institute for Cancer Research"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute for Cancer Research","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0958,"has_fulltext":false,"cited_by_count":70,"citation_normalized_percentile":{"value":0.31510389,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":99},"biblio":{"volume":"59","issue":"12","first_page":"2944","last_page":"9"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11845","display_name":"Cancer therapeutics and mechanisms","score":0.2904999852180481,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11845","display_name":"Cancer therapeutics and mechanisms","score":0.2904999852180481,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12356","display_name":"Bioactive Compounds and Antitumor Agents","score":0.16830000281333923,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12465","display_name":"Cancer, Lipids, and Metabolism","score":0.12479999661445618,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/cytarabine","display_name":"cytarabine","score":0.9610000252723694},{"id":"https://openalex.org/keywords/anticancer-activity","display_name":"anticancer activity","score":0.8109999895095825},{"id":"https://openalex.org/keywords/melanoma","display_name":"melanoma","score":0.621999979019165},{"id":"https://openalex.org/keywords/lung-adenocarcinoma","display_name":"lung adenocarcinoma","score":0.8989999890327454},{"id":"https://openalex.org/keywords/breast-cancer","display_name":"breast cancer","score":0.9520000219345093},{"id":"https://openalex.org/keywords/osteosarcoma","display_name":"osteosarcoma","score":0.9850000143051147},{"id":"https://openalex.org/keywords/leptomeningeal-metastasis","display_name":"leptomeningeal metastasis","score":0.9359999895095825},{"id":"https://openalex.org/keywords/xenograft-models","display_name":"xenograft models","score":0.6890000104904175},{"id":"https://openalex.org/keywords/drug-internalization","display_name":"drug internalization","score":0.6589999794960022}],"concepts":[{"id":"https://openalex.org/C2778041864","wikidata":"https://www.wikidata.org/wiki/Q180983","display_name":"Cytarabine","level":3,"score":0.8435660600662231},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6279721260070801},{"id":"https://openalex.org/C2778397455","wikidata":"https://www.wikidata.org/wiki/Q50429865","display_name":"Antimetabolite","level":3,"score":0.6240071654319763},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.5369330048561096},{"id":"https://openalex.org/C2777844706","wikidata":"https://www.wikidata.org/wiki/Q422504","display_name":"Deoxycytidine","level":4,"score":0.4897458553314209},{"id":"https://openalex.org/C2780258809","wikidata":"https://www.wikidata.org/wiki/Q414143","display_name":"Gemcitabine","level":3,"score":0.4816414415836334},{"id":"https://openalex.org/C2777333352","wikidata":"https://www.wikidata.org/wiki/Q2689559","display_name":"Nucleoside analogue","level":3,"score":0.4734358787536621},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4234154224395752},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.4217385947704315},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3826768398284912},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.361722469329834},{"id":"https://openalex.org/C2776543447","wikidata":"https://www.wikidata.org/wiki/Q28734","display_name":"Nucleoside","level":2,"score":0.24519744515419006},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.18816164135932922},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.1032228171825409},{"id":"https://openalex.org/C150903083","wikidata":"https://www.wikidata.org/wiki/Q7108","display_name":"Biotechnology","level":1,"score":0.0},{"id":"https://openalex.org/C71240020","wikidata":"https://www.wikidata.org/wiki/Q186011","display_name":"Stereochemistry","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000964","descriptor_name":"Antimetabolites, Antineoplastic","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000964","descriptor_name":"Antimetabolites, Antineoplastic","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D001692","descriptor_name":"Biological Transport","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D002277","descriptor_name":"Carcinoma","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D002352","descriptor_name":"Carrier Proteins","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D003561","descriptor_name":"Cytarabine","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D003561","descriptor_name":"Cytarabine","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D003561","descriptor_name":"Cytarabine","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D004195","descriptor_name":"Disease Models, Animal","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004354","descriptor_name":"Drug Screening Assays, Antitumor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005231","descriptor_name":"Fatty Acids, Unsaturated","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D005231","descriptor_name":"Fatty Acids, Unsaturated","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007939","descriptor_name":"Leukemia L1210","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D007942","descriptor_name":"Leukemia, Experimental","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D008565","descriptor_name":"Membrane Proteins","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D008807","descriptor_name":"Mice, Inbred BALB C","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008819","descriptor_name":"Mice, Nude","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009368","descriptor_name":"Neoplasm Transplantation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011923","descriptor_name":"Rats, Nude","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014183","descriptor_name":"Transplantation, Heterologous","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014407","descriptor_name":"Tumor Cells, Cultured","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D033703","descriptor_name":"Nucleoside Transport Proteins","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051381","descriptor_name":"Rats","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"pmid:10383159","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/10383159","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer research","raw_type":"Comparative Study"},{"id":"mag:1496898730","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/10383159","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.98580002784729,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":29,"referenced_works":["https://openalex.org/W7050148","https://openalex.org/W1487811436","https://openalex.org/W1539101560","https://openalex.org/W1547275364","https://openalex.org/W1548495399","https://openalex.org/W1828655749","https://openalex.org/W1895832174","https://openalex.org/W1953582277","https://openalex.org/W1957060958","https://openalex.org/W1964573195","https://openalex.org/W1966542709","https://openalex.org/W1969387960","https://openalex.org/W1977823334","https://openalex.org/W1979518464","https://openalex.org/W1991687965","https://openalex.org/W2014214643","https://openalex.org/W2060897854","https://openalex.org/W2085612023","https://openalex.org/W2087884039","https://openalex.org/W2103880407","https://openalex.org/W2107335130","https://openalex.org/W2110886624","https://openalex.org/W2110964568","https://openalex.org/W2119743709","https://openalex.org/W2120150472","https://openalex.org/W2157768631","https://openalex.org/W2169052398","https://openalex.org/W2305287298","https://openalex.org/W2413953465"],"related_works":["https://openalex.org/W2979576842","https://openalex.org/W2092442000","https://openalex.org/W4237372138","https://openalex.org/W2018283978","https://openalex.org/W2080022420","https://openalex.org/W2284960843","https://openalex.org/W2096249361","https://openalex.org/W2168624244","https://openalex.org/W4244255317","https://openalex.org/W2603723827"],"abstract_inverted_index":{"The":[0,268],"antineoplastic":[1],"efficacy":[2,44],"of":[3,13,23,45,82,92,108,110,120,135,139,148,181,188,195,205,234,260,294],"P-4055,":[4,252],"a":[5,15,57,78,99],"5'-elaidic":[6],"acid":[7],"(C18:1,":[8],"unsaturated":[9],"fatty":[10],"acid)":[11],"ester":[12],"cytarabine,":[14,142,206,248],"nucleoside":[16,235],"antimetabolite":[17],"frequently":[18],"used":[19],"in":[20,28,30,40,64,74,90,104,144,213,224,230,273,282,283,296],"the":[21,43,67,111,121,133,182,196,198,225,244,263,275,279,288,292],"treatment":[22,86],"hematological":[24],"malignancies,":[25],"was":[26,47,200],"examined":[27],"several":[29,218],"vivo":[31,284],"models":[32],"for":[33,153],"human":[34],"cancer.":[35],"In":[36,56,98,129,193,229],"initial":[37],"dose-finding":[38],"studies":[39],"nude":[41,65,105],"mice,":[42,106],"P-4055":[46,88,140,174,209,255,295],"highest":[48],"when":[49],"using":[50],"schedules":[51],"with":[52,87,118,266],"repeated":[53],"daily":[54,149],"doses.":[55],"Raji":[58,101],"Burkitt's":[59],"lymphoma":[60],"leptomeningeal":[61],"carcinomatosis":[62],"model":[63,103],"rats,":[66],"control":[68],"cytarabine-":[69],"and":[70,141,168,207,210,240,286],"saline-treated":[71],"animals":[72,113,123],"(five":[73],"each":[75],"group)":[76],"had":[77],"mean":[79],"survival":[80,125],"time":[81],"13.2":[83],"days,":[84,156],"whereas":[85],"resulted":[89],"three":[91,190],"five":[93],"long-time":[94],"survivors":[95],"(>70":[96],"days).":[97,128],"systemic":[100],"leukemia":[102],"8":[107],"10":[109],"P-4055-treated":[112],"survived":[114],"(>80":[115],"days),":[116],"compared":[117,265],"none":[119],"cytarabine-treated":[122],"(mean":[124],"time,":[126],"34.2":[127],"s.c.":[130],"xenograft":[131],"models,":[132],"effects":[134],"maximum":[136],"tolerated":[137],"doses":[138],"given":[143],"four":[145],"weekly":[146],"cycles":[147],"bolus":[150],"i.v.":[151],"injections":[152],"5":[154],"subsequent":[155],"against":[157],"seven":[158],"tumors":[159],"(three":[160],"melanomas,":[161],"one":[162,165],"lung":[163,183],"adenocarcinoma,":[164],"breast":[166],"cancer,":[167],"two":[169,194,280],"osteogenic":[170],"sarcomas)":[171],"were":[172],"investigated.":[173],"induced":[175],"partial":[176],"or":[177],"complete":[178],"tumor":[179,227],"regression":[180],"carcinoma,":[184],"as":[185,187],"well":[186],"all":[189],"malignant":[191],"melanomas.":[192],"melanomas":[197],"activity":[199],"highly":[201],"superior":[202],"to":[203,247,251],"that":[204,254],"both":[208],"cytarabine":[211],"were,":[212],"general,":[214],"more":[215],"effective":[216],"than":[217],"clinically":[219],"established":[220],"drugs":[221],"previously":[222],"tested":[223],"same":[226],"models.":[228],"vitro":[231],"studies,":[232],"inhibitors":[233],"carrier-dependent":[236],"transport,":[237],"nitrobenzylmercaptopurine":[238],"riboside":[239],"dipyridamol,":[241],"reduced":[242],"strongly":[243,290],"cellular":[245],"sensitivity":[246],"but":[249],"not":[250],"indicating":[253],"uses":[256],"an":[257],"alternative/additional":[258],"mechanism":[259],"internalization":[261],"into":[262],"cell":[264],"cytarabine.":[267],"results":[269],"explain,":[270],"at":[271],"least":[272],"part,":[274],"observed":[276],"differences":[277],"between":[278],"compounds":[281],"efficacy,":[285],"together":[287],"data":[289],"support":[291],"evaluation":[293],"clinical":[297],"studies.":[298]},"counts_by_year":[{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":1},{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":4},{"year":2019,"cited_by_count":3},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":2},{"year":2015,"cited_by_count":2},{"year":2014,"cited_by_count":5},{"year":2013,"cited_by_count":7},{"year":2012,"cited_by_count":6}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}